Emicizumab-kxwh Subcutaneous and Loestrin 1.5/30
Determining the interaction of Emicizumab-kxwh Subcutaneous and Loestrin 1.5/30 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: conjugated estrogens / medroxyprogesterone
Brand name: Premphase, Prempro
Synonyms: Conjugated estrogens and medroxyprogesterone, Estrogens (Conjugated/Equine) and Medroxyprogesterone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Loestrin 1.5/30 Oral
- Emicizumab-kxwh Subcutaneous-Loestrin 1/20
- Emicizumab-kxwh Subcutaneous-Loestrin 1/20 Oral
- Emicizumab-kxwh Subcutaneous-Loestrin 24 Fe
- Emicizumab-kxwh Subcutaneous-Loestrin Fe 1.5/30
- Emicizumab-kxwh Subcutaneous-Loestrin Fe 1/20
- Loestrin 1.5/30-Emla
- Loestrin 1.5/30-Emla Topical
- Loestrin 1.5/30-Emo-Cort Scalp Solution Topical application
- Loestrin 1.5/30-Emo-Cort Topical application
- Loestrin 1.5/30-Emoquette
- Loestrin 1.5/30-Empagliflozin